Simplex Trading’s Rubius Therapeutics, Inc RUBY Stock Holding History

Simplex Trading’s Portfolio RUBY Stock Details RUBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,856	Closed	–	–	10465
2023 Q1	$0	Buy	+3,856	New	+$803	﹤0.01%	10649
2022 Q3	–	Sell	-288	Closed	-$216	–	11311
2022 Q2	$0	Sell	288 -105,932	-100%	-$178K	﹤0.01%	11565
2022 Q1	$585K	Buy	106,220 +103,593	+3,943%	+$658K	﹤0.01%	3640
2021 Q4	$25K	Buy	2,627 +317	+14%	+$4.4K	﹤0.01%	8139
2021 Q3	$59K	Hold	2,310	–	–	﹤0.01%	7326
2021 Q2	$56K	Sell	2,310 -7,035	-75%	-$176K	﹤0.01%	7521
2021 Q1	$247K	Buy	+9,345	New	+$136K	﹤0.01%	4425

Simplex Trading's RUBY Position: Q2 2023 in Review

Simplex Trading sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2023, closing a stake of 3,856 shares.

Simplex Trading first reported a position in RUBY in Q1 2021 and held it in 7 quarters. The position peaked at $585K in Q1 2022. 0 funds tracked by Wall St. Rank hold RUBY as of Q2 2023.

Simplex Trading reported no remaining Rubius Therapeutics, Inc position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 3,856 Rubius Therapeutics, Inc shares in Q2 2023.
Simplex Trading first reported a position in Rubius Therapeutics, Inc in Q1 2021 and held it in 7 quarters.
Simplex Trading's Rubius Therapeutics, Inc position peaked at $585K in Q1 2022.
0 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.